213 OPERAM: intervention protocol Funding This work is part of the project “OPERAM: OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly” supported by the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 6342388, and by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0137. The opinions expressed and arguments employed herein are those of the authors and do not necessarily reflect the official views of the EC and the Swiss government. Trial management, recruitment, analysis, and publication were independent of the funding bodies. Informed consent Written consent was obtained from patients participating in the OPERAM trial and written consent was obtained from a patient’s next-of-kin for participating patients with cognitive impairment. Trial registration Universal Trial Number: U1111-1181-9400 Clinicaltrials.gov: NCT02986425, Registered 08 December 2016. FOPH (Swiss national portal): SNCTP000002183. Netherlands Trial Register: NTR6012 (07-10-2016). 3
RkJQdWJsaXNoZXIy MTk4NDMw